1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global 3D Bio-Printers in Medical Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for 3D Bio-Printers in Medical by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for 3D Bio-Printers in Medical by Country/Region, 2020, 2024 & 2031
2.2 3D Bio-Printers in Medical Segment by Type
2.2.1 Magnetic 3D Bioprinting
2.2.2 Laser-Assisted Bioprinting
2.2.3 Inkjet 3D Bioprinting
2.2.4 Microextrusion 3D Bioprinting
2.3 3D Bio-Printers in Medical Sales by Type
2.3.1 Global 3D Bio-Printers in Medical Sales Market Share by Type (2020-2025)
2.3.2 Global 3D Bio-Printers in Medical Revenue and Market Share by Type (2020-2025)
2.3.3 Global 3D Bio-Printers in Medical Sale Price by Type (2020-2025)
2.4 3D Bio-Printers in Medical Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Research Labs
2.4.4 Others
2.5 3D Bio-Printers in Medical Sales by Application
2.5.1 Global 3D Bio-Printers in Medical Sale Market Share by Application (2020-2025)
2.5.2 Global 3D Bio-Printers in Medical Revenue and Market Share by Application (2020-2025)
2.5.3 Global 3D Bio-Printers in Medical Sale Price by Application (2020-2025)
3 Global 3D Bio-Printers in Medical by Company
3.1 Global 3D Bio-Printers in Medical Breakdown Data by Company
3.1.1 Global 3D Bio-Printers in Medical Annual Sales by Company (2020-2025)
3.1.2 Global 3D Bio-Printers in Medical Sales Market Share by Company (2020-2025)
3.2 Global 3D Bio-Printers in Medical Annual Revenue by Company (2020-2025)
3.2.1 Global 3D Bio-Printers in Medical Revenue by Company (2020-2025)
3.2.2 Global 3D Bio-Printers in Medical Revenue Market Share by Company (2020-2025)
3.3 Global 3D Bio-Printers in Medical Sale Price by Company
3.4 Key Manufacturers 3D Bio-Printers in Medical Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers 3D Bio-Printers in Medical Product Location Distribution
3.4.2 Players 3D Bio-Printers in Medical Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2025)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for 3D Bio-Printers in Medical by Geographic Region
4.1 World Historic 3D Bio-Printers in Medical Market Size by Geographic Region (2020-2025)
4.1.1 Global 3D Bio-Printers in Medical Annual Sales by Geographic Region (2020-2025)
4.1.2 Global 3D Bio-Printers in Medical Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic 3D Bio-Printers in Medical Market Size by Country/Region (2020-2025)
4.2.1 Global 3D Bio-Printers in Medical Annual Sales by Country/Region (2020-2025)
4.2.2 Global 3D Bio-Printers in Medical Annual Revenue by Country/Region (2020-2025)
4.3 Americas 3D Bio-Printers in Medical Sales Growth
4.4 APAC 3D Bio-Printers in Medical Sales Growth
4.5 Europe 3D Bio-Printers in Medical Sales Growth
4.6 Middle East & Africa 3D Bio-Printers in Medical Sales Growth
5 Americas
5.1 Americas 3D Bio-Printers in Medical Sales by Country
5.1.1 Americas 3D Bio-Printers in Medical Sales by Country (2020-2025)
5.1.2 Americas 3D Bio-Printers in Medical Revenue by Country (2020-2025)
5.2 Americas 3D Bio-Printers in Medical Sales by Type
5.3 Americas 3D Bio-Printers in Medical Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC 3D Bio-Printers in Medical Sales by Region
6.1.1 APAC 3D Bio-Printers in Medical Sales by Region (2020-2025)
6.1.2 APAC 3D Bio-Printers in Medical Revenue by Region (2020-2025)
6.2 APAC 3D Bio-Printers in Medical Sales by Type
6.3 APAC 3D Bio-Printers in Medical Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe 3D Bio-Printers in Medical by Country
7.1.1 Europe 3D Bio-Printers in Medical Sales by Country (2020-2025)
7.1.2 Europe 3D Bio-Printers in Medical Revenue by Country (2020-2025)
7.2 Europe 3D Bio-Printers in Medical Sales by Type
7.3 Europe 3D Bio-Printers in Medical Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa 3D Bio-Printers in Medical by Country
8.1.1 Middle East & Africa 3D Bio-Printers in Medical Sales by Country (2020-2025)
8.1.2 Middle East & Africa 3D Bio-Printers in Medical Revenue by Country (2020-2025)
8.2 Middle East & Africa 3D Bio-Printers in Medical Sales by Type
8.3 Middle East & Africa 3D Bio-Printers in Medical Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of 3D Bio-Printers in Medical
10.3 Manufacturing Process Analysis of 3D Bio-Printers in Medical
10.4 Industry Chain Structure of 3D Bio-Printers in Medical
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 3D Bio-Printers in Medical Distributors
11.3 3D Bio-Printers in Medical Customer
12 World Forecast Review for 3D Bio-Printers in Medical by Geographic Region
12.1 Global 3D Bio-Printers in Medical Market Size Forecast by Region
12.1.1 Global 3D Bio-Printers in Medical Forecast by Region (2026-2031)
12.1.2 Global 3D Bio-Printers in Medical Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global 3D Bio-Printers in Medical Forecast by Type
12.7 Global 3D Bio-Printers in Medical Forecast by Application
13 Key Players Analysis
13.1 EnvisionTEC
13.1.1 EnvisionTEC Company Information
13.1.2 EnvisionTEC 3D Bio-Printers in Medical Product Portfolios and Specifications
13.1.3 EnvisionTEC 3D Bio-Printers in Medical Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 EnvisionTEC Main Business Overview
13.1.5 EnvisionTEC Latest Developments
13.2 Biobots
13.2.1 Biobots Company Information
13.2.2 Biobots 3D Bio-Printers in Medical Product Portfolios and Specifications
13.2.3 Biobots 3D Bio-Printers in Medical Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Biobots Main Business Overview
13.2.5 Biobots Latest Developments
13.3 RegenHU
13.3.1 RegenHU Company Information
13.3.2 RegenHU 3D Bio-Printers in Medical Product Portfolios and Specifications
13.3.3 RegenHU 3D Bio-Printers in Medical Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 RegenHU Main Business Overview
13.3.5 RegenHU Latest Developments
13.4 Cellink
13.4.1 Cellink Company Information
13.4.2 Cellink 3D Bio-Printers in Medical Product Portfolios and Specifications
13.4.3 Cellink 3D Bio-Printers in Medical Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Cellink Main Business Overview
13.4.5 Cellink Latest Developments
13.5 Organovo
13.5.1 Organovo Company Information
13.5.2 Organovo 3D Bio-Printers in Medical Product Portfolios and Specifications
13.5.3 Organovo 3D Bio-Printers in Medical Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Organovo Main Business Overview
13.5.5 Organovo Latest Developments
13.6 3Dynamic Systems
13.6.1 3Dynamic Systems Company Information
13.6.2 3Dynamic Systems 3D Bio-Printers in Medical Product Portfolios and Specifications
13.6.3 3Dynamic Systems 3D Bio-Printers in Medical Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 3Dynamic Systems Main Business Overview
13.6.5 3Dynamic Systems Latest Developments
13.7 Poietis
13.7.1 Poietis Company Information
13.7.2 Poietis 3D Bio-Printers in Medical Product Portfolios and Specifications
13.7.3 Poietis 3D Bio-Printers in Medical Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Poietis Main Business Overview
13.7.5 Poietis Latest Developments
13.8 Regenovo Biotechnology
13.8.1 Regenovo Biotechnology Company Information
13.8.2 Regenovo Biotechnology 3D Bio-Printers in Medical Product Portfolios and Specifications
13.8.3 Regenovo Biotechnology 3D Bio-Printers in Medical Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Regenovo Biotechnology Main Business Overview
13.8.5 Regenovo Biotechnology Latest Developments
14 Research Findings and Conclusion
※参考情報 医療用バイオ3Dプリンターは、医療分野において生体材料を用いて立体的な構造物を製造するための先進的な技術です。これは、細胞、組織、さらには臓器の再生医療や治療法の開発において重要な役割を担っています。バイオ3Dプリンティングは、依然として新しい分野ではありますが、その可能性は無限大です。 この技術の定義は、特定の生体適合性材料や細胞を使用し、三次元構造を持つ生体工学的な製品を製造することを指します。通常の3Dプリンティング技術に生体材料や細胞を組み合わせることで、より複雑な生物模倣の組織構造を実現します。これにより、医療の現場で使用される製品の研究開発と製造が加速され、患者に最適化された治療法を提供することが可能になります。 医療用バイオ3Dプリンターの特徴の一つは、ユーザーが自由に設計したモデルをプリントすることができる点です。これにより、患者の個々のニーズや病状に合わせたカスタマイズ製品を作成することができます。また、迅速なプロトタイピングが可能であり、短期間でさまざまな試作品を作成し、改善を重ねることができます。さらに、生体材質の選択肢も豊富であり、細胞培養や組織の特性に応じてさまざまな材料を使用することができます。 医療用バイオ3Dプリンターには、いくつかの種類があります。最も一般的なものは、バイオインクを使用して細胞を直接印刷できるタイプのプリンターです。このバイオインクは、細胞や生体分子を含むペースト状の材料で、特定の形状に走査されることで、細胞の生存と増殖を助ける環境を提供します。さらに、光重合技術や熱溶融押出法など、異なる製造方法に基づくプリンターも存在します。 用途においては、医療用バイオ3Dプリンターは主に以下のような分野で活用されています。まず、多くの医療機関では、患者の臓器のモデリングや手術のシミュレーションに使用されています。これは特に、複雑な手術の前に医師がより具体的に手順を把握できるようにするためのものです。さらに、再生医療の分野では、細胞を使用して人工臓器や組織の構築が進められており、臓器移植の不足を補完する取り組みとして注目されています。 また、製薬分野にもその利用が広がっています。新薬の研究開発において、3Dバイオプリンティングは多様な細胞を持つ「オンチップ」モデルを作成することができ、薬剤の効果や安全性を評価するための新たな手法を提供します。実験モデルは一層リアルで、より正確なデータを得ることができます。 関連技術としては、細胞培養技術や生体材料の研究、ナノテクノロジー、ロボティクスが挙げられます。細胞の培養技術は、生体材料を使用した3D構造の中で細胞が正常に機能するために重要です。生体材料の研究は、より適切な生体適合性を持つ材料の開発において不可欠です。また、ロボティクスや人工知能(AI)も活用され、より精密で効率的な製造を実現することが期待されています。 このように、医療用バイオ3Dプリンターは、医療分野に革命をもたらす技術として、多くの可能性を秘めています。今後も技術が進化し続けることで、個別化医療の実現や医療コストの削減が期待されます。医療用バイオプリンターの進展が、患者一人ひとりにとってより良い治療につながることを願っています。これにより、医療がより効果的で、患者のニーズに応じたものへと進化していくことが期待されています。 |
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/